Skip to main content

Advertisement

SpringerLink
Log in

Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper

  • Review
  • Published:
Cell and Tissue Research Aims and scope Submit manuscript

Abstract

Glaucoma, a chronic progressive neuropathy and the most frequent cause of irreversible blindness worldwide, is commonly treated by medication or surgery aimed at lowering intraocular pressure. In view of the limited therapeutic options, the European Glaucoma Society (EGS) sponsored two Think Tank Meetings with the goal of assessing the current status and the overall perspectives for neuroprotective treatment strategies in glaucoma. The results of the meetings are summarized in this EGS White Paper.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alencar LM, Zangwill LM, Weinreb RN, Bowd C, Vizzeri G, Sample PA, Susanna R Jr, Medeiros FA (2010) Agreement for detecting glaucoma progression with the GDx guided progression analysis, automated perimetry, and optic disc photography. Ophthalmology 117:462–470

    Article  PubMed  Google Scholar 

  • Anderson DR, Hendrickson A (1974) Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol 13:771–783

    PubMed  CAS  Google Scholar 

  • Bach M, Poloschek C (2013) Electrophysiology and glaucoma: current status and future challenges. Cell Tissue Res (this issue)

  • Baltmr A, Duggan J, Nizari S, Salt TE, Cordeiro MF (2010) Neuroprotection in glaucoma—Is there a future role? Exp Eye Res 91:554–566

    Article  PubMed  CAS  Google Scholar 

  • Berry JD, Cudkowicz ME (2011) New considerations in the design of clinical trials for amyotrophic lateral sclerosis. Clin Investig (Lond) 1:1375–1389

    Article  Google Scholar 

  • Bosco A, Steele MR, Vetter ML (2011) Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol 519:599–620

    Article  PubMed  Google Scholar 

  • Buckingham BP, Inman DM, Lambert W, Oglesby E, Calkins DJ, Steele MR, Vetter ML, Marsh-Armstrong N, Horner PJ (2008) Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci 28:2735–2744

    Article  PubMed  CAS  Google Scholar 

  • Burgoyne CF (2011) A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp Eye Res 93:120–132

    Article  PubMed  CAS  Google Scholar 

  • Chang EE, Goldberg JL (2012) Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology 119:979–986

    Article  PubMed  Google Scholar 

  • Chauhan BC, Blanchard JW, Hamilton DC, LeBlanc RP (2000) Technique for detecting serial topographic changes in the optic disc and peripapillary retina using scanning laser tomography. Invest Ophthalmol Vis Sci 41:775–782

    PubMed  CAS  Google Scholar 

  • Coleman AL (2012) Advances in glaucoma treatment and management: surgery. Invest Ophthalmol Vis Sci 53:2491–2494

    Article  PubMed  Google Scholar 

  • Collaborative Normal-Tension Glaucoma Study Group (1998a) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126:487–497

    Article  Google Scholar 

  • Collaborative Normal-Tension Glaucoma Study Group (1998b) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126:498–505

    Article  Google Scholar 

  • Cordeiro MF, Levin LA (2011) Clinical evidence for neuroprotection in glaucoma. Am J Ophthalmol 152:715–716

    Article  PubMed  Google Scholar 

  • Cordeiro MF, Guo L, Luong V, Harding G, Wang W, Jones HE, Moss SE, Sillito AM, Fitzke FW (2004) Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci USA 101:13352–13356

    Article  PubMed  CAS  Google Scholar 

  • Cordeiro MF, Nickells R, Drexler W, Borras T, Ritch R (2009) High-resolution ocular imaging: combining advanced optics and microtechnology. Ophthalmic Surg Lasers Imaging 40:480–488

    Article  PubMed  Google Scholar 

  • Cordeiro MF, Migdal C, Bloom P, Fitzke FW, Moss SE (2011) Imaging apoptosis in the eye. Eye (Lond) 25:545–553

    Article  CAS  Google Scholar 

  • Cui Q, Lu Q, So KF, Yip HK (1999) CNTF, not other trophic factors, promotes axonal regeneration of axotomized retinal ganglion cells in adult hamsters. Invest Ophthalmol Vis Sci 40:760–766

    PubMed  CAS  Google Scholar 

  • Danesh-Meyer HV, Levin LA (2009) Neuroprotection: extrapolating from neurologic diseases to the eye. Am J Ophthalmol 148:e182

    Article  Google Scholar 

  • Diekmann H, Fischer D (2013) Glaucoma and optic nerve repair. Cell Tissue Res (this issue)

  • Downs JC, Roberts MD, Burgoyne CF (2008) Mechanical environment of the optic nerve head in glaucoma. Optom Vis Sci 85:425–435

    Article  PubMed  Google Scholar 

  • Downs JC, Roberts MD, Sigal IA (2011) Glaucomatous cupping of the lamina cribrosa: a review of the evidence for active progressive remodeling as a mechanism. Exp Eye Res 93:133–140

    Article  Google Scholar 

  • Drexler W, Fujimoto JG (2008) State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res 27:45–88

    Article  PubMed  Google Scholar 

  • Duncan JL, Zhang Y, Gandhi J, Nakanishi C, Othman M, Branham KE, Swaroop A, Roorda A (2007) High-resolution imaging with adaptive optics in patients with inherited retinal degeneration. Invest Ophthalmol Vis Sci 48:3283–3291

    Article  PubMed  Google Scholar 

  • Emerich DF, Thanos CG (2008) NT-501: an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells. Curr Opin Mol Ther 10:506–515

    PubMed  CAS  Google Scholar 

  • Foster PJ, Buhrmann R, Quigley HA, Johnson GJ (2002) The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 86:238–242

    Article  PubMed  Google Scholar 

  • Gladstone DJ, Black SE, Hakim AM (2002) Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123–2136

    Article  PubMed  Google Scholar 

  • Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA (2002) The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120:714–720

    Article  PubMed  Google Scholar 

  • Götzinger E, Pircher M, Baumann B, Hirn C, Vass C, Hitzenberger CK (2008) Retinal nerve fiber layer birefringence evaluated with polarization sensitive spectral domain OCT and scanning laser polarimetry: a comparison. J Biophotonics 1:129–139

    Article  PubMed  Google Scholar 

  • Hare W, WoldeMussie E, Lai R, Ton H, Ruiz G, Feldmann B, Wijono M, Chun T, Wheeler L (2001) Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv Ophthalmol 45 (Suppl 3):S284–S289

    Article  PubMed  Google Scholar 

  • Hart RG, Pearce LA, Ravina BM, Yaltho TC, Marler JR (2009) Neuroprotection trials in Parkinson's disease: systematic review. Mov Disord 24:647–654

    Article  PubMed  Google Scholar 

  • Henchcliffe C, Severt WL (2011) Disease modification in Parkinson's disease. Drugs Aging 28:605–615

    Article  PubMed  CAS  Google Scholar 

  • Howell GR, Libby RT, Jakobs TC, Smith RS, Phalan FC, Barter JW, Barbay JM, Marchant JK, Mahesh N, Porciatti V, Whitmore AV, Masland RH, John SW (2007) Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol 179:1523–1537

    Article  PubMed  CAS  Google Scholar 

  • Joachim SC, Reichelt J, Berneiser S, Pfeiffer N, Grus FH (2008) Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens. Graefes Arch Clin Exp Ophthalmol 246:573–580

    Article  PubMed  CAS  Google Scholar 

  • Johnson TV, Bull ND, Martin KR (2011) Neurotrophic factor delivery as a protective treatment for glaucoma. Exp Eye Res 93:196–203

    Article  PubMed  CAS  Google Scholar 

  • Karl MO (2013) The potential of stem cell research for the treatment of neuronal damage in glaucoma. Cell Tissue Res (this issue)

  • Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713

    Article  PubMed  Google Scholar 

  • Kauper K, McGovern C, Sherman S, Heatherton P, Rapoza R, Stabila P, Dean B, Lee A, Borges S, Bouchard B, Tao W (2012) Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases. Invest Ophthalmol Vis Sci 53:7484–7491

    Article  PubMed  CAS  Google Scholar 

  • Kirsch M, Lee MY, Meyer V, Wiese A, Hofmann HD (1997) Evidence for multiple, local functions of ciliary neurotrophic factor (CNTF) in retinal development: expression of CNTF and its receptors and in vitro effects on target cells. J Neurochem 68:979–990

    Article  PubMed  CAS  Google Scholar 

  • Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S (2011) A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol 151:671–681

    Article  PubMed  CAS  Google Scholar 

  • Kwon YH, Fingert JH, Kuehn MH, Alward WL (2009) Primary open-angle glaucoma. N Engl J Med 360:1113–1124

    Article  PubMed  CAS  Google Scholar 

  • Lebrun-Julien F, Duplan L, Pernet V, Osswald I, Sapieha P, Bourgeois P, Dickson K, Bowie D, Barker PA, Di Polo A (2009a) Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism. J Neurosci 29:5536–5545

    Article  PubMed  CAS  Google Scholar 

  • Lebrun-Julien F, Morquette B, Douillette A, Saragovi HU, Di Polo A (2009b) Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol Cell Neurosci 40:410–420

    Article  PubMed  CAS  Google Scholar 

  • Leibinger M, Muller A, Andreadaki A, Hauk TG, Kirsch M, Fischer D (2009) Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor. J Neurosci 29:14334–14341

    Article  PubMed  Google Scholar 

  • Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121:48–56

    Article  PubMed  Google Scholar 

  • Liang J, Williams DR (1997) Aberrations and retinal image quality of the normal human eye. J Opt Soc Am A Opt Image Sci Vis 14:2873–2883

    Article  PubMed  CAS  Google Scholar 

  • Liang J, Williams DR, Miller DT (1997) Supernormal vision and high-resolution retinal imaging through adaptive optics. J Opt Soc Am A Opt Image Sci Vis 14:2884–2892

    Article  PubMed  CAS  Google Scholar 

  • Liu Y, Pang IH (2013) Challenges in the development of glaucoma neuroprotection therapy. Cell Tissue Res (this issue)

  • Nguyen JV, Soto I, Kim KY, Bushong EA, Oglesby E, Valiente-Soriano FJ, Yang Z, Davis CH, Bedont JL, Son JL, Wei JO, Buchman VL, Zack DJ, Vidal-Sanz M, Ellisman MH, Marsh-Armstrong N (2011) Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. Proc Natl Acad Sci USA 108:1176–1181

    Article  PubMed  CAS  Google Scholar 

  • Normando EM, Turner LA, Cordeiro MF (2013) The potential of annexin-labelling for the diagnosis and follow-up of glaucoma. Cell Tissue Res (this issue)

  • Patterson AJ, Garway-Heath DF, Strouthidis NG, Crabb DP (2005) A new statistical approach for quantifying change in series of retinal and optic nerve head topography images. Invest Ophthalmol Vis Sci 46:1659–1667

    Article  PubMed  Google Scholar 

  • Pease ME, Zack DJ, Berlinicke C, Bloom K, Cone F, Wang Y, Klein RL, Hauswirth WW, Quigley HA (2009) Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Invest Ophthalmol Vis Sci 50:2194–2200

    Article  PubMed  Google Scholar 

  • Pircher M, Hitzenberger CK, Schmidt-Erfurth U (2011) Polarization sensitive optical coherence tomography in the human eye. Prog Retin Eye Res 30:431–451

    Article  PubMed  Google Scholar 

  • Prasse M, Rauscher FG, Wiedemann P, Reichenbach A, Franke M (2013) Optical properties of retinal tissue and the potential of adaptive optics to visulaize retinal ganglion cells in vivo. Cell Tissue Res (this issue)

  • Quigley HA (2011) Glaucoma. Lancet 377:1367–1377

    Article  PubMed  Google Scholar 

  • Quigley H, Cone FE (2013) Development of diagnostic and treatment strategies for glaucoma through understanding and modification of scleral and lamina cribrosa connective tissue. Cell Tissue Res (this issue)

  • Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ (1995) Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36:774–786

    PubMed  CAS  Google Scholar 

  • Rao HL, Zangwill LM, Weinreb RN, Sample PA, Alencar LM, Medeiros FA (2010) Comparison of different spectral domain optical coherence tomography scanning areas for glaucoma diagnosis. Ophthalmology 117:1692–1699

    Article  PubMed  Google Scholar 

  • Reardon G, Kotak S, Schwartz GF (2011) Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence 5:441–463

    Article  PubMed  Google Scholar 

  • Reichelt J, Joachim SC, Pfeiffer N, Grus FH (2008) Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension. Curr Eye Res 33:253–261

    Article  PubMed  CAS  Google Scholar 

  • Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844–851

    PubMed  Google Scholar 

  • Seitz R, Hackl S, Seibuchner T, Tamm ER, Ohlmann A (2010) Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt/beta-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells. J Neurosci 30:5998–6010

    Article  PubMed  CAS  Google Scholar 

  • Seitz R, Ohlmann A, Tamm ER (2013) The role of Müller glia and microglia in glaucoma. Cell Tissue Res (this issue)

  • Shaarawy TM, Sherwood MB, Grehn F (2008) Guidelines on design and reporting of glaucoma surgical trials. Kugler, Amsterdam

    Google Scholar 

  • Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR, Bush RA (2006) Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA 103:3896–3901

    Article  PubMed  CAS  Google Scholar 

  • Sleath B, Blalock S, Covert D, Stone JL, Skinner AC, Muir K, Robin AL (2011) The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology 118:2398–2402

    Article  PubMed  Google Scholar 

  • Soto I, Pease ME, Son JL, Shi X, Quigley HA, Marsh-Armstrong N (2011) Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Invest Ophthalmol Vis Sci 52:434–441

    Article  PubMed  CAS  Google Scholar 

  • Strouthidis NG, White ET, Owen VM, Ho TA, Garway-Heath DF (2005) Improving the repeatability of Heidelberg retina tomograph and Heidelberg retina tomograph II rim area measurements. Br J Ophthalmol 89:1433–1437

    Article  PubMed  CAS  Google Scholar 

  • Strouthidis NG, Demirel S, Asaoka R, Cossio-Zuniga C, Garway-Heath DF (2010) The Heidelberg retina tomograph glaucoma probability score: reproducibility and measurement of progression. Ophthalmology 117:724–729

    Article  PubMed  Google Scholar 

  • Talcott KE, Ratnam K, Sundquist SM, Lucero AS, Lujan BJ, Tao W, Porco TC, Roorda A, Duncan JL (2011) Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci 52:2219–2226

    Article  PubMed  CAS  Google Scholar 

  • Tezel G, Thornton IL, Tong MG, Luo C, Yang X, Cai J, Powell DW, Soltau JB, Liebmann JM, Ritch R (2012) Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma. Invest Ophthalmol Vis Sci 53:8222–8231

    Article  PubMed  CAS  Google Scholar 

  • The AGIS Investigators (2000) The advanced glaucoma intervention study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429–440

    Article  Google Scholar 

  • Unsicker K (2013) Neurotrophic molecules in the treatment of neurodegenerative disease with focus on the retina: status and perspectives. Cell Tissue Res (this issue)

  • Voss T, Ravina B (2008) Neuroprotection in Parkinson's disease: myth or reality? Curr Neurol Neurosci Rep 8:304–309

    Article  PubMed  Google Scholar 

  • Weber AJ (2013) Autocrine and paracrine interactions and neuroprotection in glaucoma. Cell Tissue Res (this issue)

  • Weinreb RN, Kaufman PL (2009) The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci 50:1497–1505

    Article  PubMed  Google Scholar 

  • Weinreb RN, Kaufman PL (2011) Glaucoma research community and FDA look to the future. II. NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function. Invest Ophthalmol Vis Sci 52:7842–7851

    Article  PubMed  Google Scholar 

  • Werkmeister RM, Dragostinoff N, Pircher M, Gotzinger E, Hitzenberger CK, Leitgeb RA, Schmetterer L (2008) Bidirectional Doppler Fourier-domain optical coherence tomography for measurement of absolute flow velocities in human retinal vessels. Opt Lett 33:2967–2969

    Article  PubMed  Google Scholar 

  • Werkmeister RM, Cherecheanu AP, Garhofer G, Schmidl D, Schmetterer L (2013) Imaging of RGC in glaucoma: pitfalls and challenges. Cell Tissue Res (this issue)

  • Zhang K, Hopkins JJ, Heier JS, Birch DG, Halperin LS, Albini TA, Brown DM, Jaffe GJ, Tao W, Williams GA (2011) Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci USA 108:6241–6245

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank David Garway-Heath and Michael Bach for critically reading drafts of this manuscript and for providing extremely helpful comments. We also greatly appreciate invaluable insights and considerations from the European Glaucoma Society Think Tank participants:

Raffaella Aldigeri, University of Parma, Italy

Eleftherios Anastasopoulos, University of Thessaloniki, Greece

Michael Bach, University of Freiburg, Germany

Daniele Bottai, University of Milan, Italy

Helmut Brandstätter, University of Erlangen-Nürnberg, Germany

Francesca Cordeiro, Institute of Ophthalmology, London, UK

Alexandre Denoyer, INSERM, UPMC, University Paris, France

Dietmar Fischer, University of Düsseldorf, Germany

Paolo Fogagnolo, University of Milan, Italy

Mike Francke, University of Leipzig, Germany

Rudolf Fuchshofer, University of Regensburg, Germany

Stefano Gandolfi, University of Parma, Italy

David Garway-Heath, Moorfields Eye Hospital, London, UK

Franz Grehn, University of Würzburg, Germany

Franz Grus, University of Mainz, Germany

Michele Iester, University of Genoa, Italy

Mike Karl, University of Dresden, Germany

Jan Kremers, University of Erlangen-Nürnberg, Germany

Kerstin Krieglstein, University of Freiburg, Germany

Gerassimos Lascaratos, Moorfields Eye Hospital, London, UK

Eduardo Normando, Institute of Ophthalmology, London, UK

Andreas Ohlmann, University of Regensburg, Germany

Iok-Hou Pang, University of North Texas Health Science Center, TX

Norbert Pfeiffer, University of Mainz, Germany

Franziska Rauscher, University of Leipzig, Germany

Luca Mario Rossetti, University of Milan, Italy

Günther Schlunck, University of Freiburg, Germany

Leopold Schmetterer, Medical University of Vienna, Austria

Hagen Thieme, University of Magdeburg, Germany

Ernst R. Tamm, University of Regensburg, Germany

Fotis Topouzis, University of Thessaloniki, Greece

Klaus Unsicker, University of Freiburg, Germany

Author information

Authors and Affiliations

  1. Institute of Human Anatomy and Embryology, University of Regensburg, Universitätstrasse 31, 93053, Regensburg, Germany

    Ernst R. Tamm

  2. Center of Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria

    Leopold Schmetterer

  3. Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

    Leopold Schmetterer

  4. Department of Ophthalmology, University of Würzburg, Würzburg, Germany

    Franz Grehn

Authors
  1. Ernst R. Tamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leopold Schmetterer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Franz Grehn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ernst R. Tamm.

Additional information

The Think Tank Meetings were fully supported by the European Glaucoma Society.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamm, E.R., Schmetterer, L. & Grehn, F. Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper. Cell Tissue Res 353, 347–354 (2013). https://doi.org/10.1007/s00441-013-1637-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00441-013-1637-3

Keywords

Search

Navigation